White Spots on Nails: Drugs That Cause or Treat It

What Exactly Are White Spots on Nails?

White spots on the nails go by the clinical term leukonychia, derived from the Greek for "white nail." The condition is not a single diagnosis. It covers a spectrum of presentations that range from isolated white flecks caused by a stubbed finger to pale transverse bands that track heavy-metal poisoning or chemotherapy cycles.

Types of Leukonychia

Dermatologists classify leukonychia by pattern and depth. Punctate leukonychia presents as small, scattered white dots, usually on multiple fingernails, and accounts for the overwhelming majority of cases seen in primary care. Striate (transverse) leukonychia shows as one or more horizontal white bands running across the nail plate. True leukonychia originates in the nail matrix itself and moves distally as the nail grows, while apparent leukonychia reflects changes in the nail bed beneath a normal nail plate and does not move with nail growth.

Why the Distinction Matters Clinically

Apparent leukonychia that does not migrate with nail growth points toward systemic disease, liver dysfunction, or drug effects on blood vessels rather than simple trauma. A 2019 review in the British Journal of Dermatology noted that distinguishing true from apparent leukonychia with dermoscopy changes management in a meaningful proportion of cases. Compressing the nail bed with a glass slide is one quick office technique. If the white color disappears under pressure, the cause is vascular, pointing toward apparent leukonychia and a possible systemic etiology.

Common Non-Drug Causes of White Spots on Nails

Minor trauma is responsible for most white spots seen in clinical practice. Nail biters, frequent manicure recipients, and anyone who works with their hands see this presentation routinely. The white spots appear 4 to 8 weeks after the inciting injury because that is how long it takes for the damaged matrix cells to produce visibly abnormal nail plate.

Fungal Infection (Onychomycosis)

Superficial white onychomycosis (SWO) produces chalky-white patches directly on the dorsal nail plate surface. The causative organism in most SWO cases is Trichophyton mentagrophytes or, less commonly, non-dermatophyte molds. A 2014 analysis published in JAMA Dermatology of 15,000 clinic visits found onychomycosis present in approximately 14% of patients presenting with nail abnormalities. SWO is the one leukonychia subtype where antifungal treatment directly removes the white discoloration.

Nutritional and Metabolic Contributors

Zinc deficiency has been proposed as a contributor to punctate leukonychia for decades, though a 2020 systematic review in the Journal of the American Academy of Dermatology found the evidence base thin, noting that controlled studies show inconsistent serum zinc levels in patients with isolated leukonychia. Hypoalbuminemia, whether from liver disease, nephrotic syndrome, or severe malnutrition, produces Muehrcke lines, which are paired white transverse bands on multiple nails simultaneously.

Systemic Diseases That Produce Nail Whitening

Terry nails, where the nail is almost entirely white with a distal pink band, are associated with hepatic cirrhosis, congestive heart failure, and type 2 diabetes. Half-and-half nails (Lindsay nails) with a proximal white zone and a distal brown zone appear in up to 40% of patients with chronic kidney disease on dialysis, according to a study in Kidney International.

Drugs That Cause White Spots on Nails

Drug-induced nail changes are more common than many clinicians recognize. A 2021 review in Dermatology and Therapy catalogued over 40 drug classes with documented nail toxicity. White discoloration ranks among the most frequently reported nail findings.

Chemotherapy Agents

Taxanes, including paclitaxel and docetaxel, interrupt mitosis in the rapidly dividing nail matrix cells and may produce transverse white bands or diffuse leukonychia. The bands correspond to treatment cycles and are sometimes called "chemo lines." A prospective cohort study of 100 patients receiving docetaxel-based regimens, published in Supportive Care in Cancer, found nail changes in 43% of participants, with leukonychia among the three most common findings. Cyclophosphamide and doxorubicin produce similar patterns at high cumulative doses.

Antiretroviral Drugs

Zidovudine (AZT) and other nucleoside reverse transcriptase inhibitors (NRTIs) used in HIV management are documented causes of nail pigmentation changes and leukonychia. A case series published in AIDS documented transverse leukonychia in patients receiving combination antiretroviral therapy, with onset typically 8 to 12 weeks after regimen initiation. The mechanism involves mitochondrial toxicity in matrix keratinocytes.

Sulfonamides and Antibiotics

Trimethoprim-sulfamethoxazole (TMP-SMX), commonly prescribed for urinary tract infections and Pneumocystis jirovecii prophylaxis, appears in multiple case reports as a trigger for striate leukonychia. The FDA's drug label for TMP-SMX lists nail changes under rare dermatologic effects. Fluoroquinolones and tetracyclines have smaller bodies of case-report evidence.

Heavy Metals and Arsenic

Arsenic toxicity produces Mees lines, classic single transverse white bands that run the full width of one or more nails. Each band represents an acute arsenic exposure event. Because nails grow approximately 3 mm per month, a forensic examiner can estimate the timing of exposure from the band's distance from the proximal nail fold. The National Institutes of Health toxicology profile for arsenic describes Mees lines as a hallmark physical finding. Lead, thallium, and silver compounds can produce similar though less specific transverse banding.

Other Drug Classes to Know

Retinoids (isotretinoin, acitretin) prescribed for acne and psoriasis produce multiple nail changes including brittleness and whitening. Hydroxyurea, used for sickle-cell disease and polycythemia vera, causes leukonychia in a dose-dependent fashion. A pharmacovigilance analysis in the British Journal of Haematology noted nail changes in 11% of patients on long-term hydroxyurea.

Drugs Used to Treat White Spots on Nails

Treatment depends entirely on the cause. If leukonychia stems from trauma, no drug is needed. If it stems from a causative medication, stopping or substituting that drug may resolve the discoloration over 6 to 9 months as the nail plate grows out. When onychomycosis is confirmed, antifungal therapy is the standard approach.

Oral Antifungals for Onychomycosis

Terbinafine 250 mg daily for 12 weeks remains the first-line oral therapy for toenail onychomycosis and 6 weeks for fingernails. The Derby trial and subsequent meta-analyses have consistently placed terbinafine above itraconazole in mycologic cure rates. A Cochrane review of 37 randomized controlled trials (total N = 7,282) found terbinafine achieved mycologic cure in 76% of patients versus 63% for itraconazole (Cochrane Database of Systematic Reviews, 2017). Itraconazole pulse dosing (200 mg twice daily for 1 week per month for 3 months) is an alternative for patients who cannot tolerate continuous terbinafine due to hepatotoxicity risk.

Topical Antifungals

Efinaconazole 10% solution (Jublia) and tavaborole 5% solution (Kerydin) are FDA-approved topical options for mild to moderate onychomycosis. Cure rates are lower than oral agents, but topical therapy avoids systemic drug interactions. The key efinaconazole trial (N = 1,655) reported complete cure in 17.8% versus 3.3% placebo at 52 weeks, published in the Journal of the American Academy of Dermatology. Ciclopirox 8% nail lacquer is an older topical option with a complete cure rate of roughly 5 to 8%.

Managing Drug-Induced Leukonychia

No specific pharmacologic treatment exists for leukonychia caused by chemotherapy, antiretrovirals, or other systemic drugs. Cooling of the hands during infusion (cryotherapy gloves) may reduce taxane-related nail toxicity by temporarily reducing drug delivery to the nail matrix. A randomized trial of 60 patients published in Annals of Oncology found that frozen glove use during paclitaxel infusion reduced grade 2 or higher nail changes from 51% to 11%. When drug substitution is not feasible, supportive nail care (avoidance of acetone-based removers, keeping nails trimmed, using urea-based emollients) reduces secondary trauma.

How White Spots on Nails Are Diagnosed

A focused history and physical examination resolve most cases. The clinician asks about recent trauma, new medications, occupational chemical exposure, and family history of psoriasis or lichen planus, both of which produce nail changes. Confirmation of onychomycosis requires laboratory testing because clinical appearance alone has sensitivity under 60%.

Diagnostic Tests

A nail clipping with potassium hydroxide (KOH) preparation remains the fastest test, returning a result the same day with specificity around 72%. Fungal culture on Sabouraud dextrose agar identifies the organism to species level in 3 to 4 weeks, useful when first-line therapy fails. Dermoscopy of the nail (onychoscopy) adds pattern recognition for distinguishing SWO from nail psoriasis or lichen striatus without needing a biopsy. A nail plate biopsy with periodic acid-Schiff (PAS) staining achieves the highest sensitivity for onychomycosis (approximately 92%) when clinical suspicion is high and KOH is negative, per the American Academy of Dermatology onychomycosis guideline.

When Laboratory Workup Goes Beyond the Nail

Bilateral symmetrical white nail changes on multiple nails without a history of trauma or fungal risk factors call for serum albumin, liver function tests, blood urea nitrogen, creatinine, and a thorough medication reconciliation. If arsenic or heavy-metal exposure is suspected, 24-hour urine arsenic is the preferred test. Spot urine arsenic is a faster screen but subject to dietary confounding from seafood consumption.

When Should You Worry About White Spots on Nails?

Most isolated white spots in an otherwise healthy adult require no intervention. The nails grow out and the spots disappear. Several patterns, though, carry clinical urgency.

High-Concern Nail Findings

Mees lines (single horizontal band, full nail width) after a recent illness or toxin exposure need immediate evaluation for arsenic or thallium poisoning. Muehrcke lines (double paired white bands that disappear when the nail is pressed) indicate serum albumin below 2.2 g/dL in most reported series and should prompt a metabolic panel. Terry nails appearing after age 50 are associated with hepatic cirrhosis in roughly 25% of cases, per a study in the Archives of Internal Medicine. Any nail change accompanied by periungual swelling, warmth, or purulent discharge requires urgent evaluation for paronychia or subungual abscess.

Pediatric Considerations

Punctate leukonychia in children is almost always post-traumatic. Parents frequently attribute the spots to calcium deficiency, but a study in Pediatric Dermatology found no significant difference in serum calcium or zinc between children with and without leukonychia. Reassurance is appropriate.

A Clinical Decision Framework for White Nail Evaluation

This framework organizes the evaluation into three branches based on pattern and history. It is designed for primary care triage and does not replace specialist assessment.

Branch 1. Isolated punctate spots, single nail, recent history of trauma or manicure. No workup needed. Observe for 8 to 12 weeks. If spots migrate distally with nail growth, true leukonychia from trauma is confirmed.

Branch 2. White patches on the dorsal nail surface, flaky texture, one or two nails, no systemic symptoms. Obtain KOH preparation. If positive, treat as superficial white onychomycosis with topical ciclopirox or oral terbinafine depending on extent. Confirm negative drug interactions before prescribing terbinafine in patients on CYP2D6-metabolized drugs such as tricyclic antidepressants or certain beta-blockers.

Branch 3. Transverse white bands across multiple nails, bilateral, no trauma history. Full medication reconciliation first. Check serum albumin, BUN/creatinine, liver function panel, and 24-hour urine arsenic if exposure is suspected. Referral to dermatology and, depending on findings, nephrology or hepatology.

Lifestyle and Supportive Measures

No randomized trial has tested nail care routines specifically for leukonychia resolution, but expert consensus in the American Academy of Dermatology nail care guidelines recommends keeping nails trimmed to 1 to 2 mm beyond the fingertip, using a nail brush rather than a metal cuticle tool, and applying a fragrance-free moisturizer to the periungual area twice daily. Biotin supplementation (2.5 mg per day) is promoted for nail fragility, but evidence for leukonychia specifically is anecdotal. A 2017 systematic review in JAMA Dermatology found only case reports and small uncontrolled series supporting biotin for any nail condition.